FluMist: all 41 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- How Healthy Adults Respond to the Nasal Flu VaccineNot yet recruitingNCT07726862Phase 4
- A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza VaccineEnrolling by invitationNCT07545564Phase 4
- Characterizing the Human Airway Immune Response to FluMist VaccinationRecruitingNCT07177417Phase 4
- GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuERecruitingNCT06620185Not applicable
- Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)TerminatedNCT03028987Phase 4Results posted
- Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)CompletedNCT03028974Phase 4Results posted
- Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)TerminatedNCT03023709Phase 4Results posted
- Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)CompletedNCT03023683Phase 4Results posted
- The Human Mucosal Immune Responses to Influenza Virus (SLVP026)CompletedNCT03023553Phase 4Results posted
- T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012CompletedNCT03022435Phase 4Results posted
- B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)CompletedNCT03020498Phase 4Results posted
- Safety of Nasal Influenza Immunisation in Children With AsthmaCompletedNCT02866942Phase 4Results posted
- Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and AdolescentsCompletedNCT02250274Phase 4Results posted
- T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009CompletedNCT01987349Phase 4Results posted
- Home Administration of FluMist by Parents/CaregiversCompletedNCT01938170Not applicableResults posted
- Self-Administered Nasal Influenza Feasibility StudyCompletedNCT01933048Phase 4Results posted
- Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4CompletedNCT00538512Phase 4Results posted
- A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young ChildrenCompletedNCT00344305Phase 2Results posted
- Control of Epidemic Influenza Through a School-based Influenza Vaccination ProgramCompletedNCT00138294Phase 4Results posted
- Safety Study to Evaluate FluMist in Immunocompromised ChildrenCompletedNCT00112112Phase 1Results posted
- Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated VaccineActive, not recruitingNCT07232745Phase 4
- Vaccine Pandemic Preparedness Through Airway Immunology CharacterizationActive, not recruitingNCT05921448Early Phase 1
- Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04901455Early Phase 1
- Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and BloodWithdrawnNCT03884296Phase 4
- The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and InfectionCompletedNCT03453801Phase 1
- Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza InfectionCompletedNCT02597647Phase 1
- A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).CompletedNCT02143882Phase 4
- Immune Response To Intranasal Influenza VaccinationActive, not recruitingNCT01866540Not applicable
- Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus VaccinesCompletedNCT01674205Phase 1
- A Study of a Live Intranasal Influenza Vaccine in Children With CancerCompletedNCT00906750Phase 1
- Proteomic Profiling for Influenza Vaccination - FluMistCompletedNCT00385281Phase 4
- Study To Evaluate the Safety of Bivalent VaccineCompletedNCT00325481Phase 3
- A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and FlumistCompletedNCT00231907Phase 1
- Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
- Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed InfluenzaCompletedNCT00192413Phase 3
- Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy ParticipantsCompletedNCT00192335Phase 3
- Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention ProgramCompletedNCT00192218Phase 4
- Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of AgeCompletedNCT00192140Phase 4
- Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy AdultsCompletedNCT00192127Phase 3
- Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy AdultsCompletedNCT00125944Phase 3
- Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and AdolescentsCompletedNCT00091702Phase 1/2